Use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine-based therapy.
Thomas H. Cartwright
Employment or Leadership Position - McKesson Specialty Health
Consultant or Advisory Role - Celgene
Aimee Ginsburg
Employment or Leadership Position - McKesson
Stock Ownership - Celgene (B)
Lalan S. Wilfong
Employment or Leadership Position - McKesson Specialty Health
Robyn K. Harrell
Employment or Leadership Position - McKesson Specialty Health
J. Russell Hoverman
Employment or Leadership Position - McKesson Specialty Health